Get the latest news, insights, and market updates on HIMS (Hims & Hers Health, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Is Hims & Hers Health’s US$200 Million Ohio Bet Quietly Redefining Its Core Strategy (HIMS)?
Hims & Hers Health recently committed more than US$200,000,000 to expand its New Albany, Ohio operations, planning a new fulfillment, lab testing, and pharmacy facility that will double its regional footprint and add 400 jobs. This large-scale build-out, alongside new offerings in areas like weight loss and hormonal health, underscores management’s conviction in sustained demand for its personalized telehealth platform. With this US$200,000,000 Ohio expansion as a backdrop, we’ll examine how... Dec 19, 2025 - $HIMS
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover. Dec 16, 2025 - $HIMS
Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90‑Day Pullback
Hims & Hers Health (HIMS) has been on a bumpy ride, with shares up sharply this year but giving back ground over the past 3 months. This has left investors debating what the next leg looks like. See our latest analysis for Hims & Hers Health. At a share price of $36.86, Hims & Hers Health still boasts a strong year to date share price return, even after a sharp 90 day pullback that has cooled earlier momentum, while its three year total shareholder return remains eye catching for growth... Dec 16, 2025 - $HIMS
1 Stock Under $50 with Exciting Potential and 2 We Brush Off
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models. Dec 12, 2025 - $HIMS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple